Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia

Published:2019-06-28 Issue:10 Volume:66 Page:e27897
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Brown Lauren M.¹²^ORCID,Bartolo Ray C.¹,Davidson Nadia M.¹³,Schmidt Breon¹,Brooks Ian⁴,Challis Jackie⁴,Petrovic Vida⁴,Khuong-Quang Dong-Anh¹²⁵,Mechinaud Francoise¹⁵,Khaw Seong L.¹⁵⁶,Majewski Ian J.⁶⁷,Oshlack Alicia¹³,Ekert Paul G.¹²

Affiliation:

1. Murdoch Children's Research Institute; Royal Children's Hospital; Parkville Australia

2. Department of Paediatrics; University of Melbourne; Parkville Australia

3. School of BioSciences; University of Melbourne; Parkville Australia

4. Victorian Clinical Genetics Services; Murdoch Children's Research Institute; Royal Children's Hospital; Parkville Australia

5. Children's Cancer Centre, Royal Children's Hospital; Parkville Australia

6. Walter and Eliza Hall Institute; Parkville Australia

7. Faculty of Medicine, Dentistry and Health Sciences; University of Melbourne; Parkville Australia

Funder

State Government of Victoria

Children's Cancer Foundation

the Australian Government Research Training Program

Victorian Cancer Agency

National Health and Medical Research Council

SCOR

Felton Bequest

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27897/fullpdf

Reference14 articles.

1. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1;Macdonald;Acta Haematol,2002

2. 8p11 myeloproliferative syndrome: a review;Jackson;Hum Pathol,2010

3. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33);Guasch;Blood,2000

4. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature;Mozziconacci;Leuk Res,2008

5. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality;Park;Cancer Genet Cytogenet,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across pediatric and AYA sarcomas;2023-07-21

2. Mastocytosis and Myeloid Lymphoid Neoplasms with Eosinophilia;Atlas of Pediatric Hematopathology;2023-07-13

3. Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers;Oncogene;2023-05-02

4. Management of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (Ph-Like ALL);Pathogenesis and Treatment of Leukemia;2023

5. Treatment of Ph-Like Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3